Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 02:20PM ET
8.31
Dollar change
+0.01
Percentage change
0.10
%
IndexRUT P/E- EPS (ttm)-2.26 Insider Own4.47% Shs Outstand160.15M Perf Week-3.62%
Market Cap1.33B Forward P/E81.72 EPS next Y0.10 Insider Trans-0.40% Shs Float153.02M Perf Month-11.99%
Income-284.86M PEG- EPS next Q-0.60 Inst Own58.98% Short Float27.13% Perf Quarter-28.56%
Sales885.19M P/S1.50 EPS this Y73.75% Inst Trans14.29% Short Ratio6.81 Perf Half Y-57.51%
Book/sh-3.29 P/B- EPS next Y107.16% ROA-16.91% Short Interest41.51M Perf Year48.62%
Cash/sh5.74 P/C1.45 EPS next 5Y37.90% ROE- 52W Range3.53 - 23.86 Perf YTD73.08%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-65.18% Beta2.04
Dividend TTM- Quick Ratio0.93 Sales past 5Y513.29% Gross Margin66.95% 52W Low135.19% ATR (14)0.59
Dividend Ex-DateDec 13, 2007 Current Ratio0.93 EPS Y/Y TTM65.76% Oper. Margin-32.76% RSI (14)41.81 Volatility4.84% 7.53%
Employees1543 Debt/Eq- Sales Y/Y TTM-15.68% Profit Margin-32.18% Recom2.33 Target Price16.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q40.06% Payout- Rel Volume0.48 Prev Close8.30
Sales Surprise14.54% EPS Surprise3.93% Sales Q/Q-54.80% EarningsNov 12 BMO Avg Volume6.09M Price8.31
SMA20-0.78% SMA50-18.10% SMA200-19.44% Trades Volume2,233,105 Change0.10%
Date Action Analyst Rating Change Price Target Change
Jul-30-24Downgrade JP Morgan Neutral → Underweight $8
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
Today 11:33AM
05:30AM
Dec-04-24 06:07AM
03:03AM
02:00AM
09:00AM Loading…
Nov-29-24 09:00AM
Nov-21-24 03:35PM
Nov-18-24 09:00AM
Nov-15-24 04:19PM
12:04PM
12:04PM
10:46AM
07:47AM
05:21AM
02:08AM
04:28PM Loading…
Nov-14-24 04:28PM
Nov-13-24 08:00AM
02:08AM
Nov-12-24 02:43PM
02:43PM
12:52PM
10:33AM
09:48AM
09:44AM
09:20AM
08:13AM
08:05AM
08:02AM
Nov-11-24 12:49PM
09:07AM
08:58AM Loading…
08:58AM
08:30AM
06:53AM
Nov-08-24 01:02PM
Nov-06-24 01:13PM
Nov-05-24 10:00AM
Nov-04-24 04:30PM
06:00AM
Nov-01-24 09:00AM
Oct-29-24 05:45PM
Oct-26-24 12:29PM
12:29PM
Oct-23-24 05:45PM
Oct-22-24 04:00AM
Oct-21-24 09:00AM
07:45AM
Oct-19-24 06:15PM
Oct-17-24 05:45PM
10:07AM
08:18AM
07:08AM
Oct-16-24 04:34PM
03:50PM
01:20PM
11:58AM
10:56AM
10:30AM
10:07AM
09:45AM
09:16AM
08:14AM
Oct-14-24 05:19AM
Oct-11-24 01:36PM
Oct-10-24 05:45PM
Oct-09-24 05:33PM
07:00AM
Oct-08-24 09:00AM
Oct-07-24 05:49AM
Oct-06-24 01:41PM
Oct-03-24 05:45PM
03:27AM
Sep-26-24 11:39AM
Sep-25-24 09:00AM
08:00AM
Sep-23-24 05:45PM
01:15PM
Sep-17-24 05:07PM
Sep-16-24 07:52AM
Sep-13-24 01:09PM
09:25AM
07:50AM
Sep-11-24 09:00AM
Sep-05-24 10:00AM
Sep-04-24 09:25AM
09:15AM
Sep-03-24 09:35AM
Sep-02-24 10:53AM
07:34AM
Aug-30-24 04:47PM
04:19PM
04:06PM
Aug-29-24 12:00PM
Aug-28-24 09:00AM
Aug-24-24 11:20AM
Aug-22-24 02:33PM
01:41PM
Aug-14-24 09:00AM
Aug-09-24 11:09AM
Aug-08-24 12:08PM
09:15AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipOfficerSep 18 '24Proposed Sale13.007,33595,331Sep 18 04:08 PM
Trizzino JohnEVP, CCO and CBOAug 19 '24Option Exercise0.00655028,627Aug 21 04:47 PM
Kelly James PatrickEVP, CFO and TreasurerAug 16 '24Option Exercise12.962,36730,67615,652Aug 20 05:06 PM
YOUNG JAMES FDirectorJun 21 '24Sale14.097,500105,67561,760Jun 25 04:12 PM
YOUNG JAMES FDirectorJun 18 '24Sale13.727,500102,88169,260Jun 21 04:21 PM
Dubovsky FilipPresident, R&DJun 17 '24Option Exercise6.1813,90485,91180,517Jun 20 05:08 PM
Dubovsky FilipPresident, R&DJun 17 '24Sale14.4713,904201,16466,613Jun 20 05:08 PM
MCGLYNN MARGARET GDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:14 PM
Alton Gregg HDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:11 PM
DOUGLAS RICHARDDirectorJun 12 '24Option Exercise0.006,670043,920Jun 14 04:10 PM
King Rachel K.DirectorJun 12 '24Option Exercise0.006,670018,920Jun 14 04:07 PM
MOTT DAVID MDirectorJun 12 '24Option Exercise0.006,670050,470Jun 14 04:06 PM
Rodgers Richard JDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:05 PM
YOUNG JAMES FDirectorJun 12 '24Option Exercise0.006,670076,760Jun 14 04:01 PM
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM